Beam Therapeutics to Present at Jefferies 2019 Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics, a biotechnology company developing precision genetic
medicines through base editing, today announced that John Evans, chief
executive officer, will present a company overview at the Jefferies 2019
Healthcare Conference on Wednesday, June 5, 2019 at 9:30 a.m. ET. The
conference is being held June 4-7, 2019 in New York City.

About Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base
editing, a next-generation gene editing technology. Founded by leading
scientists in gene editing, Beam is pursuing therapies for serious
diseases using its proprietary base editing technology, which can make
precise edits to single bases (A, G, C, T) in DNA and RNA. Beam is
headquartered in Cambridge, Mass. For additional information, visit www.BeamTx.com.

Contacts

Media:
Katie Engleman
1AB
[email protected]

Investors:
Monique Allaire
THRUST Strategic Communications
[email protected]